Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Brief Report
88 (
6
); 781-787
doi:
10.25259/IJDVL_714_2021
pmid:
35389034

Nailfold capillaroscopy alterations in androgenetic alopecia: A cross-sectional study

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi No.2 People’s Hospital, Wuxi, Jiangsu, China
Departments of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People’s Hospital, Wuxi, Jiangsu, China
Endocrinology, Nanjing Medical University Affiliated Wuxi People’s Hospital, Wuxi, Jiangsu, China

Lei Cao, Yajuan Wu and Yuanbo Huang are co-first authors.

Corresponding author: Dr. Lei Wang, Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, 299 Qingyang Road, Wuxi, Jiangsu, China. nydwanglei@njmu.edu.cn

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Cao L, Wu Y, Huang Y, Li Z, Zhu J, Xu W, et al. Nailfold capillaroscopy alterations in androgenetic alopecia: A cross-sectional study. Indian J Dermatol Venereol Leprol 2022;88:781-87.

Abstract

Background

Androgenetic alopecia is considered to be an independent predictor of mortality from diabetes mellitus and heart disease. However, whether androgenetic alopecia causes changes in microcirculation is unknown.

Objective

The objective of the study was to investigate whether alterations in nailfold capillaries occur in androgenetic alopecia patients.

Methods

The nailfold capillaroscopy images of androgenetic alopecia patients and matched controls were collected and analyzed.

Results

The frequencies of avascular areas, dilated, bushy and bizarre capillaries and capillary disorganization, nailfold capillaroscopy scores of 2 or scores both 2 and 3 were significantly higher in the androgenetic alopecia group than in the healthy controls (9.0% vs. 0%, 57.7% vs. 19.2%, 3.8% vs. 0%, 2.8% vs. 1.3%, 3.8% vs. 0%, 38.5% vs. 12.8% and 39.7% vs. 12.8%, respectively).

Limitations

The results of this study may be biased on account of the limited sample size or the presence of an undiagnosed disease in participants which could alter the nailfold capillaries.

Conclusion

Bushy, bizarre and dilated capillaries, capillary disorganization, avascular areas and nailfold capillaroscopy scores of 2 or 2 and 3 were more common in androgenetic alopecia patients than in healthy controls. These findings indicate that abnormalities in microcirculation may be involved in androgenetic alopecia.

Keywords

Androgenetic alopecia
avascular areas
bizarre
capillaroscopy
dilated

Plain language summary

Androgenetic alopecia is the most common cause of hair loss. It is associated with metabolic syndrome, hypertension and coronary heart disease, and is considered an independent predictor of mortality from diabetes mellitus and heart disease. However, the common pathway of pathogenesis between androgenetic alopecia and systemic diseases is not clear. In this study, capillaroscope was used to observe the nailfold capillaries of all fingers, except thumbs, in participants with and without androgenetic alopecia. We found that the frequency of capillary anomalies, such as bushy, bizarre, dilated capillaries, capillary disorganization and avascular areas was higher in androgenetic alopecia patients than participants without hair loss. These findings reveal that there may be microcirculation injury in androgenetic alopecia patients which enriches our understanding of the pathogenesis of androgenetic alopecia and connects the pathogenesis of androgenetic alopecia to systemic diseases.

Introduction

Androgenetic alopecia, also known as male pattern baldness, is the combined result of an androgen-dependent process and heredity. It affects 30%, 50% and 80% of men by the ages of 30, 50 and 70 years, respectively.1,2 While androgenetic alopecia is usually considered a localized disease resulting in hair loss, an increasing number of studies have revealed associations between androgenetic alopecia and systemic diseases, such as metabolic syndrome, hypertension and coronary heart disease. Androgenetic alopecia is an independent predictor of mortality from diabetes mellitus and heart disease in both sexes.3-6 However, whether androgenetic alopecia causes changes in the microcirculation is unknown. In this study, we assessed the microcirculation in androgenetic alopecia patients and matched healthy controls by observing their nailfold capillaries.

Methods

Subjects

A total of 78 men diagnosed with androgenetic alopecia at the outpatient department of dermatology from October 2020 to January 2021 were enrolled. Comorbidities in patients with androgenetic alopecia were assessed based on their medical history and laboratory results in the past year (including routine urinalysis, blood cell count, liver and renal function tests, blood pressure, blood glucose, blood lipid level and electrocardiogram). Age- and sex-matched controls were recruited from healthy individuals visiting the Health Examination Centre of the same hospital over the same period. The control group had normal results for routine urinalysis, blood cell count, liver and renal function tests, blood glucose level, blood lipid levels and electrocardiogram; they had normal blood pressure, a body mass index below 25, no history of autoimmune diseases and no history or clinical manifestations of androgenetic alopecia. This study was approved by the ethics committee of Wuxi People’s Hospital (HS2020002). Written informed consent was obtained from all participants prior to their inclusion in this study. The exclusion criteria were as follows: (1) history of diseases that may affect nailfold capillaries, such as autoimmune disorders, Raynaud’s phenomenon, diabetes mellitus, hypertension, glaucoma or psoriasis and (2) presence of nailfold hypertrophy or trauma. Although microcirculatory dysfunction is already present in normoglycaemic subjects with metabolic syndrome,7 not all participants in this study were subjected to the full battery of tests needed to diagnose metabolic syndrome, so we did not use metabolic syndrome as an exclusion criterion. Early-onset androgenetic alopecia was defined as alopecia of a severity of at least Norwood-Hamilton Grade 3 vertex, presenting in patients aged 35 or less.

Acquisition and evaluation of nailfold capillaroscopy images

Nailfold capillaroscopy was performed using a digital microscope (Dino-Lite AM413ZT, polarization) with 200×. Before the test, the participants were seated in a room at temperature 20–25°C for 15–20 minutes.8 Thereafter, the hands of the participants were placed at their heart level, and a drop of cedar oil was applied to the target nailfold area. All fingers except thumbs were examined, and four images of each finger were captured from four different fields of the middle of the nailfold.9 Capillaries in the distal row were evaluated by three investigators using a blinded method. The nailfold capillaroscopy criteria are shown in Table 1. A semi-quantitative rating scale was adopted to score the observed capillary abnormalities (0, no changes; 1, <33% capillary alteration or reduction; 2, 33–66% capillary alteration or reduction and 3, >66% capillary alteration or reduction).10 The mean score was calculated by analyzing four consecutive one mm fields in the middle of the nailfold of each finger, the average scores of the eight fingers were added and the final value was divided by eight.11 Microhaemorrhages were divided into two types: point dotted and confluent lesions.12

Table 1: Nailfold capillaroscopy criteria
Features Definition
Capillary density Average number of capillaries per millimetre (usually 7–14/mm)
Tortuous Arterial and venous limbs are curled but do not cross
Crossed Arterial and venous limbs cross at least at one point
Ramified Abnormal connections between arterial and venous limbs, different capillaries or vascular neoplasms
Bushy Capillaries with many small branching limbs
Bizarre Abnormal morphology not conforming to the defined categories
Subpapillary plexus Vascular network at the base of a finger nailfold
Microhemorrhages Dark masses attributableto haemosiderin deposit
Dilated Diameter >20 μm
Giant Diameter >50 μm
Disorganization Complete distortion of a regular capillary pattern
Avascular areas Lack of two or more successive capillaries

mm: Millimetre; μm: Micrometre

Statistical analysis

Independent t-test was performed to compare mean ages and nailfold capillary densities between the two groups. The Chi-square test was used to compare the frequency of different capillary morphologies between groups. Fisher’s exact test was used when appropriate. All P-values were two sided, and P < 0.05 was considered to be statistically significant. Data analysis was conducted using SPSS Statistics 20.

Results

Subjects

The case group included 78 male androgenetic alopecia patients with a mean age of 29.91 ± 9.33 years (range, 18–66 years), and the control group included 78 healthy men with a mean age of 32.76 ± 10.93 years (range, 20–59 years). Differences in the ages of these two groups were not significantly different (P = 0.082). Seven (9.0%) patients had other diseases, including hyperuricemia (n = 4), hypotension (n = 1), hypoglycemia (n = 1), and hypothyroidism (n = 1). The numbers of patients with Grades 2, 3, 4, 5 and 6 androgenetic alopecia according to the Norwood-Hamilton classification scale were 11 (14.1%), 45 (57.7%), 8 (10.3%), 13 (16.7%) and 1 (1.3%), respectively.

Nailfold capillaroscopy findings

The mean nailfold capillary densities of the androgenetic alopecia group and healthy controls were 7.44 ± 0.89 and 7.35 ± 0.76 capillaries/mm, respectively [P = 0.50; Table 2]. The nailfold capillary morphologies of androgenetic alopecia patients are shown in Figure 1. Tortuous, crossed and ramified capillaries, subpapillary plexus and microhaemorrhages were more common in the androgenetic alopecia group than in healthy controls, but differences in these features were not statistically significant. [Table 2]. The frequencies of avascular areas, dilated, bushy and bizarre capillaries and capillary disorganization were statistically higher in the androgenetic alopecia group than in healthy controls [Table 2]. The androgenetic alopecia group also had significantly higher frequencies of nailfold capillaroscopy scores of 2 or 2 and 3 as compared to the control group.

Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Normal capillaries
Figure 1a:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Normal capillaries
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Tortuous capillary
Figure 1b:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Tortuous capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Crossed capillary
Figure 1c:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Crossed capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Ramified capillary
Figure 1d:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Ramified capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Bushy capillary
Figure 1e:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Bushy capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Bizarre capillary
Figure 1f:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Bizarre capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Subpapillary plexus
Figure 1g:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Subpapillary plexus
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Dilated capillary
Figure 1h:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Dilated capillary
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Microhaemorrhages (point-dotted)
Figure 1i:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Microhaemorrhages (point-dotted)
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Microhaemorrhages (confluent)
Figure 1j:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Microhaemorrhages (confluent)
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Capillary disorganization
Figure 1k:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Capillary disorganization
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Avascular areas
Figure 1l:
Nailfold capillary morphology of androgenetic alopecia patients (Dino-Lite AM413ZT, polarization, ×200): Avascular areas

Stratification analysis showed that early-onset androgenetic alopecia patients had lower nailfold capillary densities compared with late-onset patients, but all other nailfold capillaroscopy findings showed no significant differences [Table 3].

Table 2: Nailfold capillaroscopy findings in androgenetic alopecia patients and healthy controls
Features AGA (n/total, %) Control (n/total, %) P-value
Capillary density 7.44±0.89 7.35±0.76 0.50
Tortuous 57/78 (73.1) 56/78 (71.8) 0.94
Crossed 64/78 (82.1) 61/78 (78.2) 0.84
Ramified 60/78 (76.9) 41/78 (52.6) 0.14
Bushy 3/78 (3.8) 0/78 (0) 0.04
Bizarre 10/78 (12.8) 1/78 (1.3) 0.009
Subpapillary plexus 51/78 (65.4) 41/78 (52.6) 0.41
Microhaemorrhages 29/78 (37.2) 16/78 (20.5) 0.09
Point dotted 28/78 (35.9) 15/78 (19.2) 0.08
Confluent 1/78 (1.3) 1/78 (1.3) 1.00
Dilated 45/78 (57.7) 15/78 (19.2) 0.001
Giant 0/78 (0) 0/78 (0) -
Disorganization 3/78 (3.8) 0/78 (0) 0.04
Avascular areas 7/78 (9.0) 0/78 (0) 0.002
NC score
1 47/78 (60.3) 64/78 (82.1) 0.22
2 30/78 (38.5) 10/78 (12.8) 0.005
3 1/78 (1.3) 0/78 (0) 0.24
2 and 3 31/78 (39.7) 10/78 (12.8) 0.003

AGA: Androgenetic alopecia, NC: Nailfold capillaroscopy

Table 3: Stratification analysis of nailfold capillaroscopy findings in androgenetic alopecia patients
Features Onset age Family history
Early onset (n/total, %) Late onset (n/total, %) P-value Yes (n/total, %) No (n/total, %) P-value
Capillary density 7.30±0.89 7.90±0.73 0.01 7.42±0.88 7.46±0.91 0.87
Tortuous 50/60 (83.3) 14/18 (77.8) 0.86 41/50 (82.0) 23/28 (82.1) 1.00
Crossed 19/60 (31.7) 2/18 (11.1) 0.14 13/50 (26.0) 8/28 (28.6) 0.85
Ramified 44/60 (73.3) 13/18 (72.2) 0.97 37/50 (74.0) 20/28 (71.4) 0.92
Bushy 49/60 (81.7) 11/18 (61.1) 0.50 37/50 (74.0) 23/28 (82.1) 0.77
Bizarre 1/60 (1.7) 2/18 (11.1) 0.12 2/50 (4.0) 1/28 (3.6) 0.93
Subpapillary plexus 5/60 (8.3) 5/18 (27.8) 0.08 7/50 (14.0) 3/28 (10.7) 0.71
Microhaemorrhages 20/60 (33.3) 9/18 (50.0) 0.40 18/50 (36.0) 11/28 (39.3) 0.85
Point dotted 20/60 (33.3) 8/18 (44.4) 0.56 17/50 (34.0) 11/28 (39.3) 0.75
Confluent 0/60 (0) 1/18 (5.6) 0.09 1/50 (2.0) 0/28 (0) 0.35
Dilated 33/60 (55.0) 13/18 (72.2) 0.52 30/50 (60.0) 16/28 (57.1) 0.90
Giant 0/60 (0) 0/18 (0.0) - 0/50 (0) 0/28 (0) -
Disorganization 42/60 (70.0) 9/18 (50.0) 0.46 36/50 (72.0) 15/28 (53.6) 0.44
Avascular areas 3/60 (5.0) 3/18 (16.7) 0.17 3/50 (6.0) 3/28 (10.7) 0.50
NC score
1 37/60 (61.7) 10/18 (55.6) 0.82 29/50 (58.0) 18/28 (64.3) 0.79
2 23/60 (38.3) 7/18 (38.9) 0.98 21/50 (42.0) 9/28 (32.1) 0.56
3 0/60 (0) 1/18 (5.6) 0.09 0/50 (0) 1/28 (3.6) 0.15
2 and 3 23/60 (38.3) 8/18 (44.4) 0.76 21/50 (42.0) 10/28 (35.7) 0.13
Features Systemic treatment history Norwood-Hamilton classification
Yes (n/total, %) No (n/total, %) P-value Grades 1–3 (n/total, %) Grades 4–6 (n/total, %) P-value
Capillary density 7.57±0.50 7.41±0.92 0.49 7.45±0.85 7.39±1.00 0.78
Tortuous 6/7 (85.7) 58/71 (81.7) 0.93 47/56 (83.9) 17/22 (77.3) 0.83
Crossed 2/7 (28.6) 21/71 (29.6) 0.97 17/56 (30.4) 4/22 (18.2) 0.40
Ramified 5/7 (71.4) 52/71 (73.2) 0.97 45/56 (80.4) 12/22 (54.5) 0.34
Bushy 4/7 (57.1) 54/71 (76.1) 0.66 45/56 (80.4) 15/22 (68.2) 0.67
Bizarre 1/7 (14.3) 2/71 (2.8) 0.25 2/56 (3.6) 1/22 (4.5) 0.85
Subpapillary plexus 0/7 (0) 11/71 (15.5) 0.17 7/56 (12.5) 3/22 (13.6) 0.91
Microhaemorrhages 3/7 (42.9) 26/71 (36.6) 0.83 17/56 (30.4) 12/22 (54.5) 0.19
Point dotted 3/7 (42.9) 25/71 (35.2) 0.79 17/56 (30.4) 11/22 (50.0) 0.28
Confluent 0/7 (0) 1/71 (1.4) 0.67 0/56 (0) 1/22 (4.5) 0.11
Dilated 5/7 (71.4) 41/71 (57.7) 0.73 30/56 (53.6) 6/22 (27.3) 0.18
Giant 0/7 (0) 0/69 (0) - 0/56 (0) 0/22 (0) -
Disorganization 3/7 (42.9) 47/71 (66.2) 0.53 38/56 (67.9) 13/22 (59.1) 0.73
Avascular areas 0/7 (0) 6/71 (8.5) 0.30 4/56 (7.1) 2/22 (9.1) 0.79
NC score
1 4/7 (57.1) 43/71 (60.6) 0.93 36/56 (64.3) 11/22 (50.0) 0.56
2 3/7 (42.9) 27/71 (38.0) 0.87 20/56 (35.7) 10/22 (45.5) 0.60
3 0/7 (0) 1/71 (1.4) 0.67 0/56 (0) 1/22 (4.6) 0.11
2 and 3 3/7 (42.9) 28/71 (39.4) 0.91 20/56 (35.7) 11/22 (50.0) 0.46

NC: Nailfold capillaroscopy

Discussion

Nailfold capillaroscopy is a non-invasive inspection tool often used to evaluate microcirculation through examining the morphology and density of capillaries in the finger nailfold area. Nailfold capillaroscopy is mainly used for rheumatic conditions;13 it may also be used in some non-rheumatic diseases, such as diabetes mellitus, glaucoma, psoriasis and alopecia areata.14-17 Earlier studies have found that morphologically abnormal nailfold capillaries are not rare in healthy individuals.18,19 Tortuous and crossed capillaries (also known as meandering capillaries) were common in the present work, and no significant difference between the androgenetic alopecia group and healthy controls was found. Ramified, bushy and bizarre capillaries are neonatal capillaries, they may be promoted by local hypoxia and vascular endothelial growth factor stimulation and are considered a feature of late systemic sclerosis. Ramified capillaries were also visible in healthy persons in the present and previous studies,12,19 and their incidence in patients and healthy controls was not significantly different. Bushy and bizarre capillaries are rarely visible in healthy persons but commonly observed in androgenetic alopecia patients.

The subpapillary plexus is visible in 40% of healthy adults.19 This feature may be influenced by local injuries, hyperkeratosis, skin pigmentation and oedema.20 Microhaemorrhages, including focal and diffuse micropetechiae, are also visible in healthy persons.12,19 Focal microhaemorrhages may result from micro-traumas sustained in daily life, while diffuse microhaemorrhages may strongly imply an endogenous endothelial injury indicative of a microangiopathy.21 Point dotted and confluent micropetechiae are similar to focal and diffuse micropetechiae, respectively. In this study, the subpapillary plexus and microhaemorrhages were not significantly different between the two groups.

Dilated capillaries are uncommon and giant capillaries are not observed in healthy adults.19,22-24 Dilation generally represents the first sign of microvessel injury and has been considered to be a potential marker of microangiopathy.25 In our study, giant capillaries were not visible, but the incidence of dilated capillaries was significantly higher in androgenetic alopecia group than healthy controls. This finding indicates that androgenetic alopecia patients may have a higher proportion of microvessel injury than healthy controls, controls which means that microvessel injury may be associated with androgenetic alopecia.

Capillary density and capillary arrangement are important parameters in nailfold capillaroscopy examination. Normal capillary densities do not significantly vary with age or gender.18,20,26 Loss of capillaries and capillary disorganization may be associated with hypoxia; thus, these pathological changes are rare in the early stages of systemic sclerosis but become increasingly common with the progression of the fibrotic phase of the disease.27 A decrease in capillary density is a characteristic indicator of scleroderma;11,22 indeed, when the capillary density is less than 30 per five mm, the specificity of this finding to diagnose systemic sclerosis is 92%.28 When vascular density is severely reduced, a microscopic absence of vascular areas may be observed. In the present study, the capillary densities of the androgenetic alopecia patients and healthy controls were similar. Interestingly, the mean capillary density in early-onset androgenetic alopecia patients was less than in the late-onset patients, but the figures were still within the normal range. Qualitative analysis of the abnormal morphologies of early- and late-onset androgenetic alopecia showed no significant differences. No significant differences were observed between patients with and without a family history of androgenetic alopecia, with and without a history of systemic treatment, and with androgenetic alopecia Grades 1–3 versus 4–6 according to the Norwood-Hamilton’s classification scale. Avascular areas and capillary disorganization indicate that changes in microcirculation indicative of hypoxia are more common in androgenetic alopecia patients than in healthy controls, despite having a normal mean capillary density. Whether patients with severe hair loss or older patients with early-onset androgenetic alopecia show a marked reduction in vascular density is not clear. Given the limited sample size and the low number of patients with severe androgenetic alopecia included in this work, further investigation of this topic is recommended.

Because the qualitative abnormalities of nailfold capillaries cannot reflect the severity of the capillary change, a semi-quantitative scoring system was developed.10 Our results revealed that significantly higher numbers of individuals with androgenetic alopecia had nailfold capillaroscopy scores of 2 or 2 and 3 as compared to the healthy controls, but no significant difference between these two groups was observed with respect to nailfold capillaroscopy scores of 1. Nailfold capillaroscopy scores (1, 2, 3, 2 and 3) did not differ significantly between androgenetic alopecia patients when stratified by various parameters including presence and absence of family history of androgenetic alopecia, positive or negative history of systemic treatment, early- or late-onset androgenetic alopecia, and Norwood-Hamilton grades of 1–3 versus 4–6 [Table 3]. These findings suggest that androgenetic alopecia patients show more severe nailfold capillaroscopy changes than healthy persons. Pathological changes in microvascular injury may be associated with androgenetic alopecia and seem to persist irrespective of onset and treatment of androgenetic alopecia.

Recently, perifollicular inflammation and oxidative stress were reported to be the possible underlying mechanism of androgenetic alopecia.29-31 Androgenetic alopecia was associated with increased risk factors for cardiovascular disease; while cardiovascular disease was associated with inflammation, probably due to the close interaction of inflammation with oxidative stress.32 Hence, we speculate that the nailfold capillaroscopy alterations in androgenetic alopecia patients may be caused by systemic inflammation which is closely related to oxidative stress.

Limitations

The results of this study may be biased on account of the limited sample size or the presence of an undiagnosed disease (e.g., such as metabolic syndrome) in participants which could alter the nailfold capillaries. Future studies involving larger sample sizes which can also investigate any links between nailfold capillaroscopy findings with prognosis and treatment response will be helpful to further verify our findings.

Conclusion

This study found that the bushy, bizarre and dilated capillaries, capillary disorganization, avascular areas and nailfold capillaroscopy scores of 2 or 2 and 3 are significantly more frequent in androgenetic alopecia patients than in healthy controls. These findings indicate that abnormalities in microcirculation may be involved in androgenetic alopecia.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Financial support and sponsorship

Jiangsu Nature Science Foundation (BK20180165), Scientific Research Project of Wuxi Municipal Health Commission (M202127) and Wuxi Science and Technology Development Fund (N20202002).

Conflicts of interest

There are no conflicts of interest.

References

  1. , , , , , , et al. Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg. 1998;24:1330-2.
    [CrossRef] [Google Scholar]
  2. , , , , , , et al. Androgenetic alopecia in men aged 40-69 years: Prevalence and risk factors. Br J Dermatol. 2003;149:1207-13.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , . Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: A case-control study. J Med Assoc Thai. 2013;96:947-51.
    [Google Scholar]
  4. , , , . Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220-2.
    [Google Scholar]
  5. , , , . Male pattern baldness and its association with coronary heart disease: A meta-analysis. BMJ Open. 2013;3:e002537.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , . Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease. JAMA Dermatol. 2013;149:601-6.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome. Metabolism. 2008;57:1740-6.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , . Nailfold capillaroscopy in rheumatic diseases: Which parameters should be evaluated? Biomed Res Int. 2015;2015:974530.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. Nailfold capillaroscopy for day-to-day clinical use: Construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis. 2011;70:180-3.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: A two-centre study. Ann Rheum Dis. 2010;69:1092-6.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , . Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis. 2008;67:885-7.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , . Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa. 2012;41:19-26.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , . Capillaroscopy: A valuable diagnostic tool. Actas Dermosifiliogr (Engl Ed). 2019;110:347-52.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , . Nailfold capillaroscopy in diabetes mellitus. Microvasc Res. 2017;112:41-6.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , . Relationship between nailfold capillary morphology and retinal thickness and retinal vessel density in primary open-angle and angle-closure glaucoma. Acta Ophthalmol. 2020;98:e882-7.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , . Periungual capillaroscopy in psoriasis. An Bras Dermatol. 2012;87:550-3.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Videocapillaroscopic alterations in alopecia areata. Biomed Res Int. 2013;2013:160203.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , . Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis. 1996;55:507-12.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , . Nailfold capillaroscopy with USB dermatoscope: A cross-sectional study in healthy adults. Indian J Dermatol Venereol Leprol. 2020;86:33-8.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy. Microvasc Res. 2013;90:90-5.
    [CrossRef] [PubMed] [Google Scholar]
  21. . Widefield capillary microscopy: Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum. 1981;24:1159-65.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , . How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol. 2013;27:237-48.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , . Nail fold capillaroscopy: Normal findings in children and adolescents. Semin Arthritis Rheum. 1999;29:36-42.
    [CrossRef] [Google Scholar]
  24. , . Nailfold capillaroscopy in juvenile rheumatic diseases: Known measures, patterns and indications. Clin Exp Rheumatol. 2014;32(Suppl 6):S-183-8.
    [Google Scholar]
  25. , , . Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum. 2003;48:3023-30.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , . Panoramic nailfold capillaroscopy: A new reading method and normal range. Semin Arthritis Rheum. 1990;20:21-31.
    [CrossRef] [Google Scholar]
  27. , , , , . Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford). 2006;4(45 Suppl):iv43-6.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , , , , et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19:102458.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , . Hair counts in scalp biopsy of males and females with androgenetic alopecia compared with normal subjects. J Cutan Pathol. 2009;36:734-9.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , . The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. J Drugs Dermatol. 2011;10:1404-11.
    [Google Scholar]
  31. , , , , . Oxidative stress in androgenetic alopecia. J Med Life. 2016;9:79-83.
    [Google Scholar]
  32. , , , , , , et al. Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7092151.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections